Cover Image

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment

Saved in:

Bibliographic Details
Main Authors:	Hinpetch Daungsupawong (Author), Viroj Wiwanitkit (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China
by: Ruogu Meng, et al.
Published: (2023)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
by: Maria E. Sundaram, et al.
Published: (2022)

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China
by: Yuan-yuan Zhang, et al.
Published: (2023)

Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors
by: Hinpetch Daungsupawong, et al.
Published: (2023)

ChatGPT and safety of COVID-19 vaccines
by: Hinpetch Daungsupawong, et al.
Published: (2023)

ChatGPT Versus Medical Professionals: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Characteristics of measles antibodies in premature infants: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Comment on "Evaluation of the success of hysteroscopic uterine septum resection"
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Generative Artificial Intelligence in Dental Licensing Examinations: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Knowledge-map analysis and bladder cancer immunotherapy: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Comments on: Effect of physical activity on long COVID fatigue
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
by: Kandace L. Amend, et al.
Published: (2022)

Percutaneous hepatic vein recanalization in pediatric Budd-Chiari syndrome: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Potential applications of Chat Generative Pre-trained Transformer in obstetrics and gynecology: comment
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Comment on "Usability of the ROBOVID mobile app for health education about COVID-19"
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Measles vaccine uptake and COVID-19
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
by: Suzanne M. Garland, et al.
Published: (2022)

Mpox vaccination for men who have sex with men
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Commentary on "Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery"
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Surveillance analysis of adverse events following immunization with the bivalent human papillomavirus vaccine and recombinant human papillomavirus 9-valent vaccine in Hebei province from 2018 to 2022
by: Jinghui WANG, et al.
Published: (2024)

9-Valent human papillomavirus vaccine: a review of the clinical development program
by: Alain Luxembourg, et al.
Published: (2017)

Off-Label 9-Valent Human Papillomavirus Vaccination for Actinic Keratosis: A Case Series
by: Emily Wenande, et al.
Published: (2021)

Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021
by: Fuxing Chen, et al.
Published: (2022)

ChatGPT: performance and dermatology specialty certificate examination - Correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Link between donepezil and neuromuscular disorders
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Ways to make artificial intelligence work for healthcare professionals: correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Link between donepezil and neuromuscular disorders
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic"
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Artificial Intelligence, Control of Scientific Articles in Pre- and Postpublication Process
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Exploring Drug Repurposing Through Artificial Intelligence: A Novel Approach to Treating Herpes Zoster Infection
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Vitamin D Receptor Gene Polymorphisms with Type 1 Diabetes Risk: Correspondence
by: Hinpetch Daungsupawong, et al.
Published: (2024)

ChatGPT: oportunidades, riesgos, atención médica, enseñanza e investigación
by: Hinpetch Daungsupawong, et al.
Published: (2024)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
by: E. D. Moreira, et al.
Published: (2018)

Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
by: Steven Simoens, et al.
Published: (2021)

Systemic 9-valent human papillomavirus vaccine for recalcitrant common cutaneous warts in preparation for renal transplant
by: W. Austin Wyant, MSc, et al.
Published: (2022)

Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report
by: Yuan Ding, et al.
Published: (2023)

Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China
by: Yu Yang, et al.
Published: (2024)